Amwell® Announces Results for the Second Quarter 2026
Amwell reported Q2 revenue of $52.0 million, reaching the top end of guidance, with subscription revenue growing to $25.7 million. The company raised its full-year 2026 revenue outlook to $200M-$205M and significantly improved its Adjusted EBITDA guidance to a loss of ($9M)-($7M).
Key figures
- Revenue
- 52000000
- Guidance
- FY26 revenue $200M-$205M (raised from $195M-$205M); FY26 Adjusted EBITDA ($9M)-($7M) (raised from ($16M)-($12M)); Q3 revenue $46M-$48M; Q3 Adjusted EBITDA ($5M)-($3M)
- Gross margin
- 53%
- Amg visit revenue
- 24400000
- Subscription revenue
- 25700000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.